Highview Merger Corp. Class A Ordinary Share
$10.29-$0.01 (-0.1%)
Highview Merger Corp. Class A Ordinary Share’s quoted price sits in the upper half of its reported 52-week range, 0.58% below the high.
NASDAQ · DRDB · USD
Stock price, earnings
Quote as of Oct 29, 2026, 07:28 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Roman DBDR Acquisition Corp. II’s quoted price sits in the upper half of its reported 52-week range, 0.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Roman DBDR Acquisition Corp. II’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Roman DBDR Acquisition Corp. II (DRDB) functions as a special purpose acquisition company (SPAC), formed with the explicit goal of identifying and executing a business combination with another entity. This could involve various forms of strategic integration, such as a merger, an acquisition of assets or shares, or a corporate reorganization. The firm was established on July 25, 2024, and its principal headquarters are situated in Boca Raton, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.29-$0.01 (-0.1%)
Highview Merger Corp. Class A Ordinary Share’s quoted price sits in the upper half of its reported 52-week range, 0.58% below the high.
$10.89+$0.01 (+0.14%)
Drugs Made In America Acquisition Corp. Ordinary Shares’s quoted price sits in the upper half of its reported 52-week range, 0.05% below the high.
$10.77+$0.01 (+0.09%)
FACT II Acquisition Corp’s quoted price sits in the upper half of its reported 52-week range, 0.09% below the high.
$10.63$0.00 (0.0%)
Plum Acquisition Corp. IV’s quoted price sits in the lower half of its reported 52-week range, 11.42% below the high.
$10.57-$0.01 (-0.09%)
Rithm Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.28% below the high.
$10.52-$0.01 (-0.09%)
Sizzle Acquisition Corp. II’s quoted price sits in the upper half of its reported 52-week range, 0.19% below the high.
$10.85-$0.01 (-0.09%)
Newbury Street II Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 10.63% below the high.
$10.96+$0.04 (+0.37%)
Range Capital Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 6.08% below the high.